ELF · e.l.f. Beauty, Inc.
Price & Indicators
Up next
AI Brief
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA non-GAAP | $168.2M | Q1 FY2027 | — |
|
|
|||
| Adjusted EBITDA margin non-GAAP | 35% | Q1 FY2027 | — |
|
|
|||
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Household & Personal Products — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ELF
this stock
e.l.f. Beauty, Inc.
|
$5.40B | +20.3% | +24.6% | 91.4 | 13.6% |
|
PG
PROCTER & GAMBLE Co
|
$334.90B | +0.9% | +3.3% | 21.8 | 1.2% |
|
UL
Unilever PLC
|
$132.90B | -5.1% | — | — | 0.1% |
|
CL
Colgate Palmolive Co
|
$73.30B | +16.4% | +1.7% | 36.3 | 2.2% |
|
RBGLY
Reckitt Benckiser Group PLC
|
$44.64B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ELF | -7.2% | +24.1% | +1.5% | +10.3% | +20.3% |
| SPY | +0.4% | +4.5% | +13.8% | +3.9% | +13.9% |
| vs SPY | -7.6% | +19.6% | -12.3% | +6.4% | +6.4% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.